Toxicology and Poisoning Emergencies in the ED

Toxic exposures represent one of the most pharmacologically complex challenge categories encountered in emergency departments across the United States, requiring clinicians to rapidly identify causative agents, anticipate toxidrome progression, and deploy time-sensitive antidotal therapies. The American Association of Poison Control Centers (AAPCC) reported more than 2.1 million human poison exposure calls to U.S. poison centers in a single recent annual data cycle, underscoring the scale of this clinical burden. This page provides a reference-grade treatment of toxicology and poisoning emergencies as managed in the ED setting, covering pathophysiologic mechanisms, classification frameworks, diagnostic tensions, and structured response phases.

• Definition and Scope
• Core Mechanics or Structure
• Causal Relationships or Drivers
• Classification Boundaries
• Tradeoffs and Tensions
• Common Misconceptions
• Checklist or Steps (Non-Advisory)
• Reference Table or Matrix
• References

Definition and Scope

A poisoning emergency is any clinical situation in which a xenobiotic — a substance foreign to normal biochemistry — produces physiologic derangement requiring evaluation or intervention. The scope extends beyond intentional overdose to include accidental ingestion, occupational exposure, envenomation, and iatrogenic medication toxicity. Emergency departments function as the primary acute-care interface for poisoning cases; the scope of practice in emergency medicine explicitly includes toxicologic stabilization.

The AAPCC, through its National Poison Data System (NPDS), classifies poison centers as a distinct layer of the emergency medical response infrastructure. Poison center consultation is available 24 hours per day at 1-800-222-1222 in the United States and is embedded in most ED toxicology protocols as a co-management resource. Medical toxicology is also recognized as a distinct subspecialty by the American Board of Emergency Medicine (ABEM) and the American Board of Medical Specialties (ABMS), with fellowship-trained toxicologists available for consultation at academic centers.

Regulatory framing for toxicology in the ED intersects with federal and state law. EMTALA (42 U.S.C. § 1395dd) mandates a medical screening examination for any patient presenting with suspected poisoning, regardless of insurance status or the suspected intentionality of the exposure. The regulatory context for emergency medicine provides broader statutory grounding for these obligations.

Core Mechanics or Structure

Toxicity operates through disruption of one or more fundamental physiologic systems. Understanding the mechanism determines the treatment strategy.

Receptor-level interference is the dominant mechanism for most pharmaceutical overdoses. Opioids bind mu-opioid receptors in the brainstem, producing respiratory depression through suppression of the pre-Bötzinger complex respiratory rhythm generator. Benzodiazepines potentiate GABA-A receptor activity, causing CNS and respiratory depression synergistically. Tricyclic antidepressants (TCAs) block fast sodium channels (Nav1.5) in cardiac myocytes, prolonging QRS duration and predisposing to ventricular dysrhythmia.

Cellular energy disruption underlies cyanide and carbon monoxide toxicity. Cyanide inhibits cytochrome c oxidase (Complex IV of the mitochondrial electron transport chain), halting aerobic respiration regardless of oxygen availability. Carbon monoxide binds hemoglobin with an affinity approximately 240 times greater than oxygen (per NIOSH documentation), producing functional anemia while also inhibiting cytochrome oxidase at high concentrations.

Enzyme inhibition drives organophosphate and carbamate toxicity. These compounds inhibit acetylcholinesterase, causing accumulation of acetylcholine at muscarinic and nicotinic synapses. The resulting toxidrome includes bronchospasm, hypersecretion, bradycardia, miosis, and muscle fasciculations — collectively described by the SLUDGE mnemonic (Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis).

Metabolic transformation to toxic intermediates explains acetaminophen hepatotoxicity. At supratherapeutic doses, hepatic glucuronidation and sulfation pathways saturate, shunting metabolism toward CYP2E1-mediated production of N-acetyl-p-benzoquinone imine (NAPQI). NAPQI depletes glutathione stores and directly alkylates hepatocyte proteins, initiating centrilobular necrosis. The Rumack-Matthew nomogram, incorporated into FDA-approved prescribing information for N-acetylcysteine (NAC), defines treatment thresholds based on serum acetaminophen concentration plotted against time post-ingestion.

Causal Relationships or Drivers

The emergency medicine overview at this site's index contextualizes ED volume growth as a structural driver of toxicologic case load. Specific causal factors include:

Prescription drug availability: The CDC classifies opioid prescribing patterns as a primary driver of opioid overdose mortality. Synthetic opioids, principally illicitly manufactured fentanyl, accounted for more than 73,000 of approximately 107,000 total drug overdose deaths reported in the United States in 2022 (CDC, Drug Overdose Deaths, 2022).

Polypharmacy in older adults: Patients aged 65 and older carry an average of 4 to 5 concurrent prescriptions (per HHS Office of the Assistant Secretary for Planning and Evaluation data), multiplying drug-drug interaction risks and reducing the threshold for unintentional toxic exposure.

Intentional self-poisoning: Poison exposures classified as intentional — including suicide attempts — represent a distinct etiologic category requiring psychiatric co-assessment. The mental health and psychiatric emergencies in the ED page addresses the parallel evaluation pathway.

Environmental and occupational exposures: OSHA's Hazardous Waste Operations and Emergency Response Standard (29 CFR § 1910.120) governs workplace toxic exposures that may present to EDs following industrial incidents.

Substance use disorder: Stimulant, opioid, and ethanol toxicity drive a significant share of ED toxicology volume, intersecting with substance use disorder and overdose emergencies as a distinct clinical subspecategory.

Classification Boundaries

Toxicologic emergencies are classified by three overlapping frameworks:

By toxidrome: A toxidrome is a recognizable constellation of signs and symptoms corresponding to a class of agents. The five classical toxidromes are opioid (miosis, bradypnea, CNS depression), sympathomimetic (mydriasis, tachycardia, hypertension, diaphoresis), cholinergic (SLUDGE + bradycardia), anticholinergic ("mad as a hatter, blind as a bat, dry as a bone, red as a beet, hot as a hare"), and sedative-hypnotic (CNS depression without miosis or respiratory failure at moderate exposure levels).

By causative agent class: AAPCC NPDS data categorizes exposures into pharmaceutical agents (analgesics, cardiovascular drugs, antidepressants), non-pharmaceutical substances (cleaning products, hydrocarbons, pesticides), and biological agents (envenomation, mushroom toxins, bacterial toxins).

By clinical severity: The Poisoning Severity Score (PSS), developed under the European Association of Poison Centres and Clinical Toxicologists (EAPCCT) framework, grades severity from 0 (no symptoms) to 4 (fatal), providing a standardized severity language for research and interoperability.

Tradeoffs and Tensions

Activated charcoal timing: Single-dose activated charcoal remains an evidence-supported GI decontamination option but only within 1 to 2 hours of ingestion according to position statements from the American Academy of Clinical Toxicology (AACT) and EAPCCT. Administering charcoal outside this window carries aspiration risk without proportionate benefit — a tension between the impulse to "do something" and evidence-based restraint.

Whole bowel irrigation for sustained-release formulations: Polyethylene glycol-electrolyte solution (PEG-ELS) for whole bowel irrigation is indicated for ingestions of sustained-release or enteric-coated formulations, body-packing, and iron or lithium overdose. The procedure is resource-intensive and can delay other interventions, requiring clinical prioritization.

Naloxone dosing in opioid overdose: Low-dose naloxone (0.04–0.1 mg IV) is favored by many toxicologists to avoid precipitating acute withdrawal and agitation, especially in opioid-dependent patients. High-dose fentanyl exposure may require escalating doses up to 10 mg or more; this creates a dosing tension where inadequate reversal risks respiratory failure while over-reversal creates a combative, withdrawal-precipitated patient with a short window of reversal before resedation.

Empiric antidote use: Some antidotes — thiamine for Wernicke's, dextrose for hypoglycemia, naloxone for opioids — are low-risk enough to justify empiric administration in the undifferentiated comatose patient. Others, such as physostigmine for anticholinergic toxicity, carry seizure and dysrhythmia risk and require confirmed clinical indication before use.

Common Misconceptions

Misconception: Ipecac-induced emesis is a standard decontamination tool. The American Academy of Pediatrics formally withdrew its recommendation for home ipecac use in 2003, and AACT position statements do not support routine ipecac use in the ED. The practice has been abandoned based on evidence that it does not improve outcomes and may delay definitive care.

Misconception: A normal acetaminophen level rules out toxicity. Serum acetaminophen levels drawn before 4 hours post-ingestion cannot be reliably plotted on the Rumack-Matthew nomogram. A level drawn at 2 hours may appear non-toxic while the 4-hour level would cross the treatment threshold.

Misconception: Pupils are a reliable sole indicator of opioid overdose. Miosis is characteristic of opioid toxidrome but is absent in meperidine overdose (which may produce mydriasis or normal pupils) and can be confounded by coingestants. Relying on pupil size alone as a diagnostic criterion risks misclassification.

Misconception: Discharge is safe once a patient is alert after naloxone reversal. Naloxone's half-life of 60 to 90 minutes is shorter than most opioid agonists. Resedation after apparent clinical recovery is a documented failure mode, particularly with long-acting or high-potency synthetic opioids.

Checklist or Steps (Non-Advisory)

The following represents the structural sequence used in ED toxicologic emergency management as described in published emergency medicine references including Tintinalli's Emergency Medicine and UpToDate toxicology modules:

1. Immediate stabilization: Airway patency, breathing adequacy, and circulatory status assessed; supplemental oxygen and monitoring attached; IV access established.
2. Toxidrome identification: Vital signs, pupil size, skin moisture, bowel sounds, and neurologic status assessed for pattern recognition.
3. Poison center consultation: AAPCC regional center contacted (1-800-222-1222) for agent-specific guidance; consultation documented.
4. History acquisition: Time of ingestion, substance identity, quantity, coingestants, and patient weight obtained from patient, family, EMS, or scene information.
5. Targeted laboratory and ECG evaluation: Acetaminophen and salicylate levels obtained in undifferentiated overdose; blood glucose, electrolytes, renal function, anion gap, osmol gap, and co-oximetry obtained based on clinical suspicion; 12-lead ECG obtained to assess QRS and QTc.
6. Decontamination decision: Activated charcoal administration considered based on agent, ingestion timing, airway protection status, and clinical trajectory per AACT guidelines.
7. Antidote administration: Agent-specific antidote administered where indicated (e.g., NAC for acetaminophen, naloxone for opioids, fomepizole for toxic alcohol, hydroxocobalamin for cyanide, atropine plus pralidoxime for organophosphates).
8. Disposition determination: Admission to ICU, monitored floor, or psychiatry; observation period calibrated to agent half-life and clinical trajectory; regional poison center or medical toxicology consulted for complex cases.

Reference Table or Matrix

References

• American Association of Poison Control Centers (AAPCC) — National Poison Data System (NPDS)
• CDC — Drug Overdose Deaths, 2022 Data
• American Academy of Clinical Toxicology (AACT) — Position Statements on GI Decontamination
• American Board of Emergency Medicine (ABEM) — Medical Toxicology Subspecialty Certification
• NIOSH — Carbon Monoxide Hazard
• OSHA — 29 CFR § 1910.120, Hazardous Waste Operations and Emergency Response
• FDA — N-acetylcysteine (Acetadote) Prescribing Information and Rumack-Matthew Nomogram Reference
• European Association of Poison Centres and Clinical Toxicologists (EAPCCT) — Poisoning Severity Score
• HHS Office of the Assistant Secretary for Planning and Evaluation — Polypharmacy in Older Adults

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)